Psychiatry and Neurology, Neurology · Metairie, LA
NPI
1003088915
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2905 Kingman St
Metairie, LA, 70006
Phone (504) 885-3737
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,564
91 services
Medicare patients, 2024
29
Average age 67
Drug cost, 2024
$590K
2,127 prescriptions
Company payments, 2025
$15K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy W Voigt was code 99214 (office e&m - established), 26 times for 15 patients. In total Amy W Voigt billed 91 services in 6 codes, and Medicare paid $7,564.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 26 | 15 | $84.18 | $2,189 |
By year: 2022 $10K for 121 services; 2023 $6,438 for 84 services; 2024 $7,564 for 91 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy W Voigt prescribed most often to Medicare patients was Butalbital-Acetaminophen-Caffe (Butalb/Acetaminophen/Caffeine), with 151 prescriptions and refills. In total Amy W Voigt wrote 2,127 Medicare prescriptions that cost $590K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 151 | 151 | 24 | $3,577 |
| Sumatriptan Succinate Generic | 141 | 145 | 23 | $6,397 |
| Aimovig Autoinjector Erenumab-Aooe | 121 | 123 | 12 | $90K |
| Rizatriptan Rizatriptan Benzoate | 99 | 101 | 17 | $1,817 |
| Amitriptyline Hcl Generic | 83 | 99 | 11 | $670 |
| Botox Onabotulinumtoxina | 68 | 188 | 22 | $86K |
| Topiramate Generic | 68 | 94 | 12 | $392 |
| Butorphanol Tartrate Generic | 65 | 65 | Under 11 | $11K |
| Promethazine Hcl Generic | 64 | 64 | Under 11 | $582 |
| Tramadol Hcl Generic | 63 | 63 | Under 11 | $498 |
| Levetiracetam Generic | 54 | 106 | 11 | $1,178 |
| Ubrelvy Ubrogepant | 54 | 54 | Under 11 | $82K |
| Baclofen Generic | 51 | 51 | Under 11 | $520 |
| Ondansetron Odt Ondansetron | 48 | 48 | Under 11 | $894 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 46 | 46 | Under 11 | $32K |
Brand drugs: 486 claims; generic drugs: 1,624 claims; opioid claims: 148.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy W Voigt $15K ($15K in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 47 | $14K |
| Novartis Pharmaceuticals Corporation NVS | 11 | $168 |
| UCB, Inc. UCB.BR | 6 | $162 |
| Lundbeck LLC | 5 | $132 |
| TG Therapeutics, Inc. TGTX | 5 | $117 |
| Genentech USA, Inc. ROG.SW | 5 | $85.81 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $75.04 |
| Merz Pharmaceuticals, LLC | 2 | $50.93 |
| Biogen, Inc. BIIB | 2 | $45.2 |
| Tanabe Pharma America, Inc. | 2 | $43.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.